Hypertension in Older Adults: Causes, Risks, and Management

Understand the specific physiology and tailored management needed to control blood pressure in older adults and avoid serious complications.

High blood pressure in older adults stems largely from age-driven changes in the arteries themselves, and it remains the single most common modifiable risk factor for heart disease, stroke, kidney failure, and dementia in this age group. Unlike hypertension in younger people, which often involves elevated diastolic pressure, the pattern in older adults skews toward isolated systolic hypertension, a signature of stiffened arteries that have lost their ability to stretch and recoil with each heartbeat. Treating it effectively requires navigating a set of challenges that barely exist for younger patients, from wider blood pressure swings to drug interactions with arthritis medications to cognitive decline that quietly undermines pill-taking.

Why Blood Pressure Climbs with Age

The central driver is structural change in the large elastic arteries, especially the aorta. Over decades, the elastin fibers that give arteries their springiness fragment and fray, while stiffer collagen fibers accumulate and become disorganized. The arterial wall thickens and the vessel widens. The net effect is a pipe that no longer absorbs the surge of blood pumped out with each heartbeat, so systolic pressure (the top number) climbs while diastolic pressure (the bottom number) may actually fall.

Alongside these structural changes, the inner lining of blood vessels gradually loses its ability to produce nitric oxide, a molecule that signals arteries to relax and widen. This decline in nitric oxide is driven largely by rising oxidative stress within the vessel wall, creating a feedback loop where damage begets more damage. The same impairment shows up in both healthy aging and in conditions like atherosclerosis and hypertension, making it harder to tease apart what is “normal” aging from early disease.

Hormonal shifts matter too. With aging, overall levels of circulating renin and aldosterone (the hormones that regulate blood volume and vessel tone) decline, but within the tissues themselves the balance tips in the wrong direction. The branch of this system that promotes vessel constriction, inflammation, and scarring becomes more active, while the branches that counteract those effects weaken. At the same time, the autonomic nervous system shifts toward higher sympathetic (“fight or flight”) activity and reduced parasympathetic (“rest and digest”) tone, nudging blood pressure upward and making the cardiovascular system less adaptable to moment-to-moment changes.

Menopause as an Accelerator

Women tend to develop hypertension later than men, but that gap narrows sharply after menopause. A large analysis of UK Biobank data found that postmenopausal women had significantly higher arterial stiffness than premenopausal women, and menopause itself was independently associated with about a 40 percent higher odds of reaching a high-stiffness threshold after accounting for age and other factors. The mechanism ties back to the nitric oxide story: estrogen normally supports the molecular machinery that keeps nitric oxide flowing. When estrogen drops, that machinery falters, and arterial compliance falls with it. Research on postmenopausal women showed that supplementing a cofactor involved in nitric oxide production improved artery compliance and vessel dilation, while the same supplement had no effect in premenopausal women, whose system was already working well.

This means that for many women, the transition around menopause represents a critical window when vascular health can deteriorate rapidly. Awareness of this shift can inform the timing of screening and lifestyle changes.

What Uncontrolled Hypertension Does to the Body

Persistently high blood pressure in older adults does not simply raise the risk of a single catastrophic event; it quietly damages multiple organ systems over years.

Brain

Hypertension, particularly during midlife and extending into later years, is linked to damage in the brain’s small blood vessels. This includes white matter lesions, microbleeds, and brain shrinkage, all of which are markers of cerebral small vessel disease. These changes raise the risk of both clinical stroke and dementia. The connection is strong enough that researchers consider small vessel disease a plausible bridge between hypertension and cognitive decline.

Heart

In older adults, hypertension is a major risk factor for a form of heart failure where the heart pumps with normal force but cannot relax and fill properly between beats. This condition, heart failure with preserved ejection fraction, is common in the elderly and carries substantial morbidity and mortality. Controlling blood pressure is widely considered central to both preventing and managing it.

Kidneys

The kidneys’ delicate filtering units are vulnerable to high-pressure damage. Long-standing hypertension causes scarring of the small arteries within the kidney, a condition that can be a definite cause of chronic kidney failure. In a study of patients with kidney dysfunction attributed to hypertension, the vast majority showed clear structural damage from high blood pressure as the sole explanation for their declining kidney function.

Why Measuring Blood Pressure Gets Trickier with Age

Getting an accurate read on an older person’s blood pressure is harder than it sounds, and an unreliable reading can lead to either overtreating or undertreating the problem.

White coat hypertension, where readings spike in a clinical setting but are normal at home, is common. But there is also a subtler variant that is more prevalent in older adults: patients whose office readings are high and whose out-of-office readings are lower, yet still not truly normal. These patients tend to have higher daytime and nighttime pressures than classic white coat cases. The flip side, masked hypertension, is arguably more dangerous: blood pressure looks fine in the office but runs high during daily life. In one study of elderly treated patients, about a third of those with normal clinic readings actually had uncontrolled pressure when monitored over 24 hours.

On top of these measurement quirks, older adults experience wider blood pressure swings throughout the day, partly because the baroreflex, the body’s built-in pressure stabilizer, weakens with age. A sluggish baroreflex means the system is slower to correct sudden drops (such as standing up quickly) or spikes (during stress or exertion). That variability itself is a risk factor for falls, fainting, and cardiac events. Home blood pressure monitoring and ambulatory monitoring are therefore more valuable in older adults than in younger ones, because a single office reading captures only one frame of a movie that is constantly shifting.

When Hypertension Has a Treatable Cause

Most hypertension in older adults is “primary,” meaning it arises from the cumulative vascular changes already described. But a meaningful fraction of older patients, especially those with blood pressure that suddenly worsens or resists multiple medications, have a secondary cause worth investigating. The most common culprit in older adults is atherosclerotic renal artery stenosis, a narrowing of the arteries feeding the kidneys. Beyond driving resistant hypertension, this can lead to progressive kidney damage and cardiac destabilization, including episodes of sudden pulmonary edema. Identifying it matters because it sometimes changes the treatment approach entirely.

How Low Should Blood Pressure Go?

This is the question that has generated the most debate in geriatric hypertension over the past decade. For years, many clinicians were cautious about pushing blood pressure below 140/90 in older adults, worrying about dizziness, falls, and kidney problems. That thinking shifted substantially after the SPRINT trial, which compared a systolic target under 120 mmHg (intensive) to a target under 140 mmHg (standard) in adults at high cardiovascular risk. The trial was stopped early because the intensive group had a roughly 25 percent lower rate of major cardiovascular events.

The benefits extended to the oldest participants. A secondary analysis focusing specifically on adults 80 and older found that intensive treatment reduced cardiovascular events by about a third, cut overall mortality by a similar margin, and even lowered the risk of mild cognitive impairment. A meta-analysis pooling SPRINT with other trials of intensive blood pressure control in people over 60 confirmed reductions in major cardiovascular events and stroke.

Yet a lower target is not automatically right for every older person. The participants in SPRINT were screened for fitness to participate, meaning they were generally healthier and more independent than many real-world elderly patients. People who are frail, have significant cognitive impairment, or need help with daily activities may not tolerate aggressive blood pressure lowering. Geriatric researchers have emphasized that a “one size fits all” target cannot be applied to very old patients because of the enormous functional differences among them. Proposed approaches include assessing frailty and daily-living independence before choosing a target, using a more relaxed goal for patients who are fragile and a tighter one for those who are robust.

Medication Choices and Common Pitfalls

First-line drug classes for older adults with hypertension typically include thiazide-type diuretics, ACE inhibitors, angiotensin receptor blockers, and long-acting calcium channel blockers. Which one to reach for first remains a matter of some debate, because age-related changes in physiology, the high burden of coexisting conditions, and the specific side-effect profiles of each class all complicate the decision. Diuretics, for example, are effective but carry a heightened risk of electrolyte imbalances in older patients.

One of the most underappreciated problems in managing hypertension in older adults is the effect of common pain medications. Nonsteroidal anti-inflammatory drugs (NSAIDs), widely used for arthritis and joint pain, cause the body to retain sodium and can push systolic blood pressure up by about 5 mmHg on average. The interaction is not uniform across drug classes: research shows that NSAIDs can blunt the effect of ACE inhibitors more than the effect of calcium channel blockers. If you are taking a blood pressure medication and your doctor adds an NSAID or you start taking one over the counter, monitoring your blood pressure becomes especially important.

The Adherence Problem

Even the best-chosen medication fails if it stays in the bottle. Adherence drops as the number of prescribed medications rises, a pattern especially relevant for older adults who often take drugs for several conditions simultaneously. A study of elderly hypertensive patients found a significant association between polypharmacy and poor adherence, highlighting the value of simplifying regimens where possible, such as using combination pills that package two drugs in one tablet.

Cognitive decline adds another layer. Research has shown that medication adherence worsens progressively as cognitive function drops, even before a person meets the threshold for a dementia diagnosis. Memory and executive function are essential for planning and executing a daily pill schedule, and subtle impairments can lead to missed doses, doubled doses, or dropped refills without the patient fully realizing what is happening. Pill organizers, reminder apps, caregiver involvement, and periodic cognitive screening all become part of hypertension management in a way they never are for younger adults.

Exercise and Diet as Vascular Therapy

Lifestyle changes are easy to dismiss as token advice, but the evidence for their vascular effects in older adults is concrete. Aerobic exercise, even over a relatively short period, has been shown to reduce arterial stiffness in older adults with multiple cardiovascular risk factors. One trial found that just a few weeks of moderate aerobic training lowered measures of pulse-wave velocity in both the arms and legs by roughly 14 to 21 percent compared with a non-exercising control group. That is worth noting because arterial stiffness, as described earlier, is the central mechanical driver of systolic hypertension in this age group. Exercise is one of the few interventions that can partially reverse it rather than merely compensating with medication.

On the dietary side, the DASH eating pattern (rich in vegetables, fruits, whole grains, lean protein, and low in sodium and saturated fat) was developed specifically to address the decline in nitric oxide that underlies age-related vascular dysfunction. Beyond its general nutritional profile, the diet supplies nitrate from leafy greens and root vegetables, which the body can convert into nitric oxide through an alternative pathway that bypasses the aging enzyme system. This makes it especially relevant for older adults, whose primary nitric oxide production is already compromised.

Arterial Stiffness Testing and Where It Fits

Standard blood pressure measurement tells you the pressure inside the system at one moment, but it does not tell you how stiff the pipes are. Pulse wave velocity, a measure of how fast a pressure wave travels along the aorta, captures that. In a cohort of over 700 patients with hypertension, aortic pulse wave velocity turned out to be the strongest predictor of cardiovascular death at any given age, outperforming more conventional markers. It was also strongly correlated with the extent of atherosclerosis.

Pulse wave velocity testing is noninvasive and relatively quick, typically performed with pressure sensors placed at the neck and groin. It is not yet a routine part of every older adult’s checkup, but it is increasingly used in research settings and in some specialized hypertension clinics to stratify risk and guide treatment intensity. For patients whose blood pressure numbers look borderline, a high pulse wave velocity can tip the balance toward more aggressive treatment. For patients already on medication, it offers a way to track whether the underlying arterial stiffness is improving, which standard blood pressure readings alone cannot reveal. As the population ages and the technology becomes more portable, there is a strong case for its wider adoption.